BOSTON–PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics,announced the acquisition of Agilix Corporation’s proprietary proteomics technology. Agilix has developed a powerful labeling technology using isobaric mass tags that allows for the simultaneous quantification of molecules, such as proteins, from multiple samples. This technology now brings quantitative proteomics to PerkinElmer customers in drug discovery and proteomics research. Furthermore, it provides a powerful technique for enhancing the utility of mass spectrometry, a preferred method for proteomic analysis. Terms of the deal were not disclosed.